CareDx shares are trading lower. The company announced that it responded to Natera's filing of a motion for an injunction related to patent 11,111,544.
Portfolio Pulse from Benzinga Newsdesk
CareDx shares are trading lower after the company announced it responded to Natera's filing of a motion for an injunction related to patent 11,111,544.
May 29, 2024 | 2:49 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CareDx shares are trading lower following the company's response to Natera's motion for an injunction related to patent 11,111,544.
The legal dispute with Natera over patent 11,111,544 has created uncertainty, leading to a decline in CareDx's stock price. Investors are likely concerned about potential legal costs and the impact on the company's operations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100